Table 3.

Baseline demographic and clinical characteristics of interobserver agreement cohort (part 2)

	No. of patients*(n = 50)
Age at surgery (years), mean (range)	66.4 (40–83)
Sex ratio (M : F)	26 : 24
Neoadjuvant therapy
Gemcitabine × 3 and RTx × 1	15
FOLFIRINOX ≥ 4 cycles	30
FOLFIRINOX < 4 cycles	3
Gemcitabine/nabpaclitaxel ≥ 3 cycles	2
Type of surgery
Pancreatoduodenectomy	39
Distal pancreatectomy	10
Total pancreatectomy	1

^*Unless otherwise indicated. FOLFIRINOX, combination treatment consisting of leucovorin, fluorouracil, irinotecan, and oxaliplatin. RTx, radiotherapy.